| 13:00-13:10 |
Welcome address |
Yong Man Kim (Congress President) |
| Xiaohua Wu (President of EAGOT, CHSGO) |
| Dae Yeon Kim (President of KGOG) |
| Aikou Okamoto (President of JGOG) |
| Chyong-Huey Lai (President of TGOG) |
| |
Special Session |
Chair : Jae Kwan Lee (Korea) |
| 13:10-13:30 |
Aiming to Prevent Ovarian Cancer Deaths through Early Detection |
Mikio Mikami (Japan) |
| |
Session 1 |
Chair : Jae Hoon Kim (Korea)
Chyong-Huey Lai (Taiwan) |
| 13:30-13:50 |
Current state and next plan of clinical trial in GYN cancer through industrial view I (MSD) |
Soo Yeon Ihm (MSD) |
| 13:50-14:10 |
Recent trend and real world data of cervical cancer treatment through radiation oncology view |
Chen-Bin Chang (Taiwan) |
| 14:10-14:30 |
Future step of cervical cancer treatment based on ongoing and planning clinical trial |
Hiroshi Nishio (Japan) |
| 14:30-14:50 |
Distillation and Panel Discussion: Further consideration points of different data among EAST Asian Countries in clinial trial & real world data |
Jun Zhu (China)
Sung Jong Lee (Korea) |
| 14:50-15:00 |
Break |
|
| |
Session 2 |
Chair : TBD person
Ting-Chang Chang (Taiwan) |
| 15:00-15:20 |
New deveoped Immuno-Oncolgy drug based on world leading innovative mechanism |
Yiwen GU (Akesobio) |
| 15:20-15:40 |
Recent trend of Endometrial cancer Treatment based on Molecular pattern |
Tatsuyuki Chiyoda (Japan) |
| 15:40-16:00 |
Endometrial cancer screening: the power and promise of Pap DNA methylation |
Hung-Cheng Lai (Taiwan) |
| 16:00-16:20 |
Distillation and Panel Discussion: Further Consderation points of different data among EAST Asian countries in clinial trial & real world data |
Yulan Ren (China)
Jeong Yeal Park (Korea) |
| 16:20-16:30 |
Break |
|
| |
Session 3 |
Chair : Soon Beom Kang
Toru Sugiyama (Japan) |
| 16:30-16:50 |
AZK's current state and next plan for clinical trial in GYN cancer : industrial view 2 (AstraZeneca) |
Zeng Xiaoling (AstraZeneca) |
| 16:50-17:10 |
Recent trend, SOC and Real world Data of Ovarian Cancer Treatment |
Kenta Masuda (Japan) |
| 17:10-17:30 |
Future Step of Ovarian cancer Treatment based on Ongoing and Planning clinical trial |
Zheng Feng (China) |
| 17:30-17:50 |
Distillation and Panel Discussion: Further Consideration points of different data among EAST Asian countries in clinial trial & real world data |
Angel Chao (Taiwan)
Kyung-Jin Min (Korea) |
| 17:50~ |
Closing remark |
|
| 19:00-21:00 |
Dinner (invitation only) |
|
